CardioDx logo — Empowering personalized cardiovascular care through advanced...

CardioDx

Empowering personalized cardiovascular care through advanced genomic diagnostics.

Founded 2004 Venture round Total: $313.86M Biotechnology, Health Care +1

General Information

Company Name CardioDx
Founded Year 2004
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CardioDx. To contact CardioDx, visit cardiodx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CardioDx compare?

A PDF of CardioDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CardioDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CardioDx

CardioDx is a biotechnology startup based in Palo Alto, CA, that has been dedicated to empowering personalized cardiovascular care through advanced genomic diagnostics since its founding in 2004. This pioneering company focuses on creating scientifically validated genomic tests to enhance the assessment and management of various cardiovascular conditions, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Notably, CardioDx secured a significant $22.50M Venture Round investment on 05 January 2017, with key backing from Artiman Ventures, Longitude Capital, and Temasek Holdings. This funding is expected to further propel CardioDx's endeavors in the biotechnology, healthcare, and pharmaceutical industries.

Business keywords: Cardiovascular Genomic Diagnostics, Genomic Testing, Coronary Artery Disease, Cardiac Arrhythmias, Heart Failure, Personalized Medicine, Healthcare Innovation, Clinical Diagnostics, Precision Medicine

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $22.50M 3
Artiman Ventures, Longitude Capital +1
05 Jan 2017
Series D $12.37M -
17 Jun 2016
Debt Financing $20.00M -
01 Jan 2015
Venture Round $35.00M 1
Alberta Investment Management
18 Dec 2014
Private Equity Round $20.98M 1
Asset Management Ventures
24 Jul 2014
Private Equity Round $58.00M 5
Kleiner Perkins, Artiman Ventures +3
27 Aug 2012
Private Equity Round $30.51M -
01 Jul 2012
Private Equity Round $60.00M -
11 May 2011
Series D $34.50M -
17 May 2010
Series C $20.00M -
23 Oct 2008

CardioDx Alternatives & Competitors

View All Alternatives
CardioDx vs

Pioneering the future of cardiovascular health with innovative miRNA biomarkers to enhance diagnosis...

Venture round
Biotechnology, Health Care
CardioDx vs
Prolocor
Prolocor United States

Advancing patient care by empowering physicians with effective precision diagnostics for cardiovascu...

Convertible Note
8 employees
Biotechnology, Health Care
CardioDx vs

Clinical Genetics and Precision Medicine. Safeguarding your future health.

Post-IPO Equity
47 employees
Biotechnology, Health Care

FAQ About CardioDx

Empowering personalized cardiovascular care through advanced genomic diagnostics.
CardioDx was founded in 2004.
CardioDx operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Cardiovascular Genomic Diagnostics, Genomic Testing, Coronary Artery Disease and Cardiac Arrhythmias.
CardioDx has completed 10 funding rounds, raising a total of $313.86M. The latest funding stage is Venture round.
Top alternatives and competitors to CardioDx include Mirnext, Prolocor, GENinCode Predictive Genetics , Iverson Genetic Diagnostics, Heartflow. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardioDx and Mirnext are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CardioDx, https://bouncewatch.com/company/cardiodx, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes